NEW YORK, Oct. 1 - Orchid Biosciences has said it will acquire DNA analysis company Lifecodes in a $12.6 million all-stock deal, Orchid said on Monday.  

Terms of the agreement, which have been approved by both firms’ boards of directors, call for Orchid to issue roughly 6.5 million new shares of common stock in exchange for all of Lifecodes’ outstanding equity.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.